Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Takeda Pharmaceutical Company Limited
FDA Inspection
•Takeda Pharmaceutical Company Limited•September 25, 2019

Takeda Pharmaceutical Company Limited – FDA Inspection, Sep 25, 2019

Record Details

This FDA Inspection record concerns Takeda Pharmaceutical Company Limited, with an inspection on September 25, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company
Takeda Pharmaceutical Company Limited
Inspection Date
September 25, 2019
Product Type
Biologics
Office
Center for Biologics Evaluation and Research
People
  • Allison A. Wellman (Issuing Officer)
  • Burnell M. Henry (FDA Associated Person)
View Company Profile

ID · f815b5da-2d6a-4e03-8688-006a8fbebf36

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1103189
FDA center
Biologics
Project area
Blood and Blood Products
Outcome
Form 483 issued

FDA Citations

3
  1. 21 CFR 640.81(c)Microbial contamination
  2. 21 CFR 807.22(a)Initial registration and listing
  3. 21 CFR 123.8(a)(3)(ii)Corrective action record review adequacy

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Takeda Pharmaceutical Company Limited

2
DateClassificationOfficeProject area
November 26, 2025Not classifiedChicago District OfficeBlood and Blood Products
September 15, 2022VAICenter for Biologics Evaluation and ResearchBlood and Blood Products
Other documents for Takeda Pharmaceutical Company Limited
  • FDA Inspection 1293098 - 2025-11-26
  • FDA Inspection 1179911 - 2022-09-15

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Takeda Pharmaceutical Company Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.